Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00134017 · OUTCOME

Chimerism

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer · Source last updated 2018-08-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Day 30, Day 60

What was measured

Number of patients who achieved 100% donor chimerism.

Analysis population: The study data was analyzed early after 117 participants had been treated. This was done in order to publish the data and establish a new local standard of care at our institution. Chimerism data was not collected on the remaining 25 participants. One participant died prior to Day 30 and was not analyzed for this outcome.

Groups in this outcome

Bone Marrow Transplant

Myeloablative bone marrow transplant with a busulfan (Bu), cyclophosphamide (Cy), preparative regimen and post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Bone Marrow Transplant116

Reported measurements

Day 30
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Bone Marrow Transplant99Not reportedNot reportedNot reportedNot reported
Day 60
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Bone Marrow Transplant101Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        99
    title
    Day 30
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        101
    title
    Day 60
denoms
  1. counts
    1. group Id
      OG000
      value
      116
    units
    Participants
description
Number of patients who achieved 100% donor chimerism.
groups
  1. description
    Myeloablative bone marrow transplant with a busulfan (Bu), cyclophosphamide (Cy), preparative regimen and post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis.
    id
    OG000
    title
    Bone Marrow Transplant
param Type
COUNT_OF_PARTICIPANTS
population Description
The study data was analyzed early after 117 participants had been treated. This was done in order to publish the data and establish a new local standard of care at our institution. Chimerism data was not collected on the remaining 25 participants. One participant died prior to Day 30 and was not analyzed for this outcome.
reporting Status
POSTED
time Frame
Day 30, Day 60
title
Chimerism
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice